Axelmark soars after Ascella Biosystems, a company in which it invests, receives a grant from the National Institutes of Health

Axelmark soars after Ascella Biosystems, a company in which it invests, receives a grant from the National Institutes of Health
The accelerator mark soared. The announcement that Ascella Biosystems, which is developing the innovative AscellaOne diagnostic technology, has won a $600,000 grant from the National Institutes of Health's RADx program, seems to be stimulating the stock price....

The linked article is in Japanese.